These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14720534)

  • 21. Perioperative antiplatelet therapy: a knife-edged choice between thrombosis and bleeding still based on consensus rather than evidence.
    Peter K; Myles PS
    Thromb Haemost; 2011 May; 105(5):750-1. PubMed ID: 21384077
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Sartori C; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Platelets; 2016 Sep; 27(6):576-82. PubMed ID: 27540959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet pathophysiology, pharmacology, and function in coronary artery disease.
    Ibrahim H; Kleiman NS
    Coron Artery Dis; 2017 Nov; 28(7):614-623. PubMed ID: 28644213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.
    Arima Y; Kaikita K; Ishii M; Ito M; Sueta D; Oimatsu Y; Sakamoto K; Tsujita K; Kojima S; Nakagawa K; Hokimoto S; Ogawa H
    J Thromb Haemost; 2016 Apr; 14(4):850-9. PubMed ID: 26773298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
    Alexopoulos D; Katogiannis K; Sfantou D; Lekakis J
    Platelets; 2018 May; 29(3):228-237. PubMed ID: 29022423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent therapeutic approaches to platelet activation in coronary artery disease.
    Tousoulis D; Paroutoglou IP; Papageorgiou N; Charakida M; Stefanadis C
    Pharmacol Ther; 2010 Aug; 127(2):108-20. PubMed ID: 20546778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease.
    Farag M; Gorog DA
    Curr Pharm Des; 2017; 23(9):1315-1327. PubMed ID: 28137225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation.
    Kleiman NS
    J Am Coll Cardiol; 2004 Jun; 43(11):1989-91. PubMed ID: 15172402
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
    Ben-Dor I; Kleiman NS; Lev E
    Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
    Price MJ
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelets treatment in atherosclerotic renal artery stenosis: need of consensus-based recommendations.
    Caielli P; Pengo MF; Ragazzo F; Rossi GP; Calò LA
    J Hypertens; 2011 Nov; 29(11):2279-81. PubMed ID: 21989383
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiplatelet agents in hemodialysis.
    Migliori M; Cantaluppi V; Scatena A; Panichi V
    J Nephrol; 2017 Jun; 30(3):373-383. PubMed ID: 27928736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updates in antiplatelet agents used in cardiovascular diseases.
    Cheng JW
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expert consensus document on the use of antiplatelet agents].
    Patrono C; Bachmann F; Baigent C; Bode C; De Caterina R; Charbonnier B; Fitzgerald D; Hirsh J; Husted S; Kvasnicka J; Montalescot G; García Rodríguez LA; Verheugt F; Vermylen J; Wallentin L;
    Rev Esp Cardiol; 2004 Oct; 57(10):963-80. PubMed ID: 15469794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.